Nikki R. Kong

1.0k citations
20 papers · 638 indexed · h-index 15
Topics
Renal and related cancers (10 papers)Pluripotent Stem Cells Research (6 papers)Epigenetics and DNA Methylation (6 papers)

In The Last Decade

Nikki R. Kong

20 papers receiving 629 citations

Peers

Nikki R. Kong
Comparison fields: 5 of 67
  • Molecular Biology 571
  • Oncology 92
  • Hematology 57
  • Pulmonary and Respiratory Medicine 48
  • Public Health, Environmental and Occupational Health 43
Replace Barbara Schnieders with:
Barbara Schnieders United States
H. Eugene Liu Taiwan
Helen Pak Canada
Sonya H.L. Lam Canada
Valentina Agnusdei Italy
Anna Wojtuszkiewicz Netherlands
Roman Galeev Sweden
Christine Mione Kiefer United States
Roel H. Wilting Netherlands
Barbara Szymanska Australia
Nikki R. Kong relative to Barbara Schnieders United States Barbara Schnieders's profile →
Citations per field
00.5×11.1×
Barbara Schnieders · 1×
Citations per year

Countries citing papers authored by Nikki R. Kong

Since Specialization
Citations

This map shows the geographic impact of Nikki R. Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikki R. Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikki R. Kong more than expected).

Fields of papers citing papers by Nikki R. Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikki R. Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikki R. Kong. The network helps show where Nikki R. Kong may publish in the future.

Co-authorship network of co-authors of Nikki R. Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Nikki R. Kong. A scholar is included among the top collaborators of Nikki R. Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikki R. Kong. Nikki R. Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 29
2 27
3 1
4 41
5 7
6 8
7 21
8 33
9 1
10 86
11 28
12 14
13 26
14 40
15 27
16 27
17 134
18 17
19 68
20 3

About Nikki R. Kong

Nikki R. Kong is a scholar working on Molecular Biology, Hematology and Oncology, having authored 20 papers that have together received 638 indexed citations. Recurring topics across this work include Renal and related cancers (10 papers), Pluripotent Stem Cells Research (6 papers) and Epigenetics and DNA Methylation (6 papers). The work is most often cited by research in Molecular Biology (571 citations), Hematology (57 citations) and Oncology (92 citations). Nikki R. Kong has collaborated with scholars based in United States, Singapore and China. Frequent co-authors include Li Chai, Chong Gao, Lyn H. Jones, Daniel G. Tenen, Youyang Yang, Leslie E. Silberstein, Hongbo R. Luo, Ha‐Won Jeong, John P. Carroll and Wei Cui. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026